1,147
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Treating methicillin-resistant Staphylococcus aureus (MRSA) bone infection with focused ultrasound combined thermally sensitive liposomes

, ORCID Icon, , &
Article: 2211278 | Received 20 Jan 2023, Accepted 02 May 2023, Published online: 12 Jul 2023

References

  • Schwarz EM, Parvizi J, Gehrke T, et al. 2018 International Consensus Meeting on Musculoskeletal Infection: research priorities from the general assembly questions. J Orthop Res. 2019;37(5):997–1006.
  • Lattwein KR, Shekhar H, Kouijzer JJ, et al. Sonobactericide: an emerging treatment strategy for bacterial infections. Ultrasound Med Biol. 2020;46(2):193–215.
  • Masters EA, Trombetta RP, de Mesy Bentley KL, et al. Evolving concepts in bone infection: redefining “biofilm”, “acute vs. chronic osteomyelitis”, “the immune proteome” and “local antibiotic therapy”. Bone Res. 2019;7(1):20.
  • Hofstee MI, Muthukrishnan G, Atkins GJ, et al. Current concepts of osteomyelitis: from pathologic mechanisms to advanced research methods. Am J Pathol. 2020;190(6):1151–1163.
  • Ma D, Shanks RMQ, Davis CM III, et al. Viable bacteria persist on antibiotic spacers following two‐stage revision for periprosthetic joint infection. J Orthop Res. 2018;36(1):452–458.
  • Jiranek WA, Hanssen AD, Greenwald AS. Antibiotic-loaded bone cement for infection prophylaxis in total joint replacement. J Bone Joint Surg Am. 2006;88(11):2487–2500.
  • Wardlow R, Bing C, VanOsdol J, et al. Targeted antibiotic delivery using low temperature-sensitive liposomes and magnetic resonance-guided high-intensity focused ultrasound hyperthermia. Int J Hyperthermia. 2016;32(3):254–264.
  • Bachu VS, Kedda J, Suk I, et al. High-Intensity focused ultrasound: a review of mechanisms and clinical applications. Ann Biomed Eng. 2021;49(9):1975–1991.
  • Ashar H, Ranjan A. Immunomodulation and targeted drug delivery with high intensity focused ultrasound (HIFU): Principles and mechanisms. Pharmacol Ther. 2023;244:108393. doi: 10.1016/j.pharmthera.2023.108393.
  • Maples D, McLean K, Sahoo K, et al. Synthesis and characterisation of ultrasound imageable heat-sensitive liposomes for HIFU therapy. Int J Hyperthermia. 2015;31(6):674–685.
  • Maurer N, Wong KF, Hope MJ, et al. Anomalous solubility behavior of the antibiotic ciprofloxacin encapsulated in liposomes: a 1H-NMR study. Biochim Biophys Acta. 1998;1374(1–2):9–20.
  • Tazina E, Kostin K, Oborotova N. Specific features of drug encapsulation in liposomes (a review). Pharm Chem J. 2011;45(8):481–490.
  • Lew DP, Waldvogel FA. Osteomyelitis. Lancet. 2004;364(9431):369–379.
  • Santos-Ferreira I, Bettencourt A, Almeida AJ. Nanoparticulate platforms for targeting bone infections: meeting a major therapeutic challenge. Nanomedicine. 2015;10(20):3131–3145.
  • Ferreira M, Aguiar S, Bettencourt A, et al. Lipid-based nanosystems for targeting bone implant-associated infections: current approaches and future endeavors. Drug Deliv Transl Res. 2021;11(1):72–85.
  • Pitt WG, McBride MO, Lunceford JK, et al. Ultrasonic enhancement of antibiotic action on gram-negative bacteria. Antimicrob Agents Chemother. 1994;38(11):2577–2582.
  • Rediske AM, Roeder BL, Brown MK, et al. Ultrasonic enhancement of antibiotic action on Escherichia coli biofilms: an in vivo model. Antimicrob Agents Chemother. 1999;43(5):1211–1214.
  • Ensing GT, Roeder BL, Nelson JL, et al. Effect of pulsed ultrasound in combination with gentamicin on bacterial viability in biofilms on bone cements in vivo. J Appl Microbiol. 2005;99(3):443–448.
  • Rediske AM, Roeder BL, Nelson JL, et al. Pulsed ultrasound enhances the killing of Escherichia coli biofilms by aminoglycoside antibiotics in vivo. Antimicrob Agents Chemother. 2000;44(3):771–772.
  • Rieck B, Bates D, Zhang K, et al. Focused ultrasound treatment of abscesses induced by methicillin resistant Staphylococcus aureus: feasibility study in a mouse model. Med Phys. 2014;41(6):063301.
  • Wardlow R, Sahoo K, Dugat D, et al. High intensity focused ultrasound (HIFU) heating improves perfusion and antimicrobial efficacy in mouse Staphylococcus abscess. Ultrasound Med Biol. 2018;44(4):909–914.
  • Patel M, Rojavin Y, Jamali AA, et al. Animal models for the study of osteomyelitis. Semin Plast Surg. 2009;23(02):148–154.
  • Lebeaux D, Chauhan A, Rendueles O, et al. From in vitro to in vivo models of bacterial biofilm-related infections. Pathogens. 2013;2(2):288–356.
  • Lucke M, Schmidmaier G, Sadoni S, et al. A new model of implant‐related osteomyelitis in rats. J Biomed Mater Res B Appl Biomater. 2003;67(1):593–602.
  • Pulido L, Ghanem E, Joshi A, et al. Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res. 2008;466(7):1710–1715.
  • Kaplan SL. Recent lessons for the management of bone and joint infections. J Infect. 2014;68:S51–S56.
  • Gade ND, Qazi MS. Fluoroquinolone therapy in Staphylococcus aureus infections: where do we stand? J Lab Physicians. 2013;5(2):109–112.
  • Fang CH, Tsai PI, Huang SW, et al. Magnetic hyperthermia enhance the treatment efficacy of peri-implant osteomyelitis. BMC Infect Dis. 2017;17(1):516.
  • Carli AV, Bhimani S, Yang X, et al. Quantification of peri-implant bacterial load and in vivo biofilm formation in an innovative. J Bone Joint Surg Am. 2017;99(6):e25.
  • Spagnolo N, Greco F, Rossi A, et al. Chronic staphylococcal osteomyelitis: a new experimental rat model. Infect Immun. 1993;61(12):5225–5230.
  • Solberg BD, Gutow AP, Baumgaertner MR. Efficacy of gentamycin-impregnated resorbable hydroxyapatite cement in treating osteomyelitis in a rat model. J Orthop Trauma. 1999;13(2):102–106.
  • Littlewood-Evans A, Hattenberger M, Lüscher C, et al. Local expression of tumor necrosis factor alpha in an experimental model of acute osteomyelitis in rats. Infect Immun. 1997;65(8):3438–3443.
  • Haenle M, Zietz C, Lindner T, et al. A model of implant-associated infection in the tibial metaphysis of rats. Sci World J. 2013;2013:481975.
  • Yin L-Y, Manring MM, Calhoun JH. A rabbit osteomyelitis model to simulate multibacterial war wound infections. Mil Med. 2013;178(6):696–700.
  • Ibelli T, Templeton S, Levi-Polyachenko N. Progress on utilizing hyperthermia for mitigating bacterial infections. Int J Hyperthermia. 2018;34(2):144–156.
  • LeBel M. Ciprofloxacin: chemistry, mechanism of action, resistance, antimicrobial spectrum, pharmacokinetics, clinical trials, and adverse reactions. Pharmacotherapy. 1988;8(1):3–33.
  • Dalhoff A. Quinolone resistance in Pseudomonas aeruginosa and Staphylococcus aureus. Development during therapy and clinical significance. Infection. 1994;22(S2):S111–S121.
  • Mulligan M, Ruane P, Johnston L, et al. Ciprofloxacin for eradication of methicillin-resistant Staphylococcus aureus colonization. Am J Med. 1987;82(4A):215–219.
  • Carmen JC, Roeder BL, Nelson JL, et al. Ultrasonically enhanced vancomycin activity against Staphylococcus epidermidis biofilms in vivo. J Biomater Appl. 2004;18(4):237–245.
  • Vollmer AC, Kwakye S, Halpern M, et al. Bacterial stress responses to 1-megahertz pulsed ultrasound in the presence of microbubbles. Appl Environ Microbiol. 1998;64(10):3927–3931.
  • Bhatia E, Sharma S, Jadhav K, et al. Combinatorial liposomes of berberine and curcumin inhibit biofilm formation and intracellular methicillin resistant Staphylococcus aureus infections and associated inflammation. J Mater Chem B. 2021;9(3):864–875.
  • Portilla S, Fernández L, Gutiérrez D, et al. Encapsulation of the antistaphylococcal endolysin LysRODI in pH-sensitive liposomes. Antibiotics. 2020;9(5):242.
  • Rukavina Z, Vanić Ž. Current trends in development of liposomes for targeting bacterial biofilms. Pharmaceutics. 2016;8(2):18.
  • Ferreira M, Pinto SN, Aires-da-Silva F, et al. Liposomes as a nanoplatform to improve the delivery of antibiotics into Staphylococcus aureus biofilms. Pharmaceutics. 2021;13(3):321.
  • Staruch R, Chopra R, Hynynen K. Localised drug release using MRI-controlled focused ultrasound hyperthermia. Int J Hyperthermia. 2011;27(2):156–171.
  • de Smet M, Heijman E, Langereis S, et al. Magnetic resonance imaging of high intensity focused ultrasound mediated drug delivery from temperature-sensitive liposomes: an in vivo proof-of-concept study. J Control Release. 2011;150(1):102–110.
  • VanOsdol J, Ektate K, Ramasamy S, et al. Sequential HIFU heating and nanobubble encapsulation provide efficient drug penetration from stealth and temperature sensitive liposomes in colon cancer. J Control Release. 2017;247:55–63.
  • Ektate K, Munteanu MC, Ashar H, et al. Chemo-immunotherapy of colon cancer with focused ultrasound and Salmonella-laden temperature sensitive liposomes (thermobots). Sci Rep. 2018;8(1):13062.
  • Al-Ahmady ZS, Scudamore CL, Kostarelos K. Triggered doxorubicin release in solid tumors from thermosensitive liposome–peptide hybrids: critical parameters and therapeutic efficacy. Int J Cancer. 2015;137(3):731–743.
  • de Matos MBC, Beztsinna N, Heyder C, et al. Thermosensitive liposomes for triggered release of cytotoxic proteins. Eur J Pharm Biopharm. 2018;132:211–221.
  • Gasselhuber A, Dreher MR, Partanen A, et al. Targeted drug delivery by high intensity focused ultrasound mediated hyperthermia combined with temperature-sensitive liposomes: computational modelling and preliminary in vivo validation. Int J Hyperthermia. 2012;28(4):337–348.
  • Hijnen N, Langereis S, Grüll H. Magnetic resonance guided high-intensity focused ultrasound for image-guided temperature-induced drug delivery. Adv Drug Deliv Rev. 2014;72:65–81.
  • Fleury B, Kelley WL, Lew D, et al. Transcriptomic and metabolic responses of Staphylococcus aureus exposed to supra-physiological temperatures. BMC Microbiol. 2009;9(1):76.
  • Gera N, Doores S. Kinetics and mechanism of bacterial inactivation by ultrasound waves and sonoprotective effect of milk components. J Food Sci. 2011;76(2):M111–M119.
  • Nguyen T-K, Duong HTT, Selvanayagam R, et al. Iron oxide nanoparticle-mediated hyperthermia stimulates dispersal in bacterial biofilms and enhances antibiotic efficacy. Sci Rep. 2015;5:18385.
  • Kaplan JB, Fine DH. Biofilm dispersal of Neisseria subflava and other phylogenetically diverse oral bacteria. Appl Environ Microbiol. 2002;68(10):4943–4950.